Insulin-like growth factor-I inhibition with pasireotide decreases cell proliferation and increases apoptosis in pre-malignant lesions of the breast: a phase 1 proof of principle trial-Reference-Cited by-同舟云学术

Insulin-like growth factor-I inhibition with pasireotide decreases cell proliferation and increases apoptosis in pre-malignant lesions of the breast: a phase 1 proof of principle trial

Published:2014-11-11 Issue:6 Volume:16 Page:
ISSN:1465-542X
Container-title:Breast Cancer Research
language:en
Short-container-title:Breast Cancer Res

Author:

Singh Baljit,Smith Julia A,Axelrod Deborah M,Ameri Pietro,Levitt Heather,Danoff Ann,Lesser Martin,de Angelis Cristina,Illa-Bochaca Irineu,Lubitz Sara,Huberman Daniel,Darvishian Farbod,Kleinberg David L

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/article/10.1186/s13058-014-0463-1/fulltext.html

Reference35 articles.

1. Nelson HD, Smith ME, Griffin JC, Fu R: Use of medications to reduce risk for primary breast cancer: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2013, 158: 604-614. 10.7326/0003-4819-158-8-201304160-00005.

2. Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM, Vogel V, Robidoux A, Dimitrov N, Atkins J, Daly M, Wieand S, Tan-Chiu E, Ford L, Wolmark N: Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst. 1998, 90: 1371-1388. 10.1093/jnci/90.18.1371.

3. Cummings SR, Eckert S, Krueger KA, Grady D, Powles TJ, Cauley JA, Norton L, Nickelsen T, Bjarnason NH, Morrow M, Lippman ME, Black D, Glusman JE, Costa A, Jordan VC: The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation. JAMA. 1999, 281: 2189-2197. 10.1001/jama.281.23.2189.

4. Coopey SB, Mazzola E, Buckley JM, Sharko J, Belli AK, Kim EM, Polubriaginof F, Parmigiani G, Garber JE, Smith BL, Gadd MA, Specht MC, Guidi AJ, Roche CA, Hughes KS: The role of chemoprevention in modifying the risk of breast cancer in women with atypical breast lesions. Breast Cancer Res Treat. 2012, 136: 627-633. 10.1007/s10549-012-2318-8.

5. Ruan W, Catanese V, Wieczorek R, Feldman M, Kleinberg DL: Estradiol enhances the stimulatory effect of insulin-like growth factor-I (IGF-I) on mammary development and growth hormone-induced IGF-I messenger ribonucleic acid. Endocrinology. 1995, 136: 1296-1302.

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decoding the Role of Insulin-like Growth Factor 1 and Its Isoforms in Breast Cancer;International Journal of Molecular Sciences;2024-08-27

2. Breast Cancer Management: The Role of Nutrition, Exercise and Psychosocial Well-being;Current Cancer Therapy Reviews;2024-03-11

3. Assessment of IGF-1 expression in the peripheral blood of women with recurrent breast cancer;Medicine;2020-10-23

4. Insulin growth factor-1 pathway in cervical carcinoma cancer stem cells;Molecular and Cellular Biochemistry;2020-06-29

5. Breast Cancer Prevention-Is there a Future for Sulforaphane and Its Analogs?;Nutrients;2020-05-27